FDA label
What is Onfi used for?
Onfi contains clobazam. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ONFI® (clobazam) is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Onfi?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Onfi, tablet
Indications and Usage, quoted from the label by Lundbeck Pharmaceuticals LLC (NDA202067). Cross-references to other label sections are left out.
ONFI® (clobazam) is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Source: DailyMed label, set id de03bd69-2dca-459c-93b4-541fd3e9571c, version 42, effective March 12, 2024. NDC 67386-314, one of 2 listings for this product.
Questions
What is Onfi used for?
The FDA label says: “ONFI® (clobazam) is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.”
What drug class is Onfi?
FDA lists clobazam in the Benzodiazepine established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Onfi
- Is Onfi a controlled substance?Schedule IV
- Generic for OnfiFDA Orange Book
- What is Clobazam used for?FDA label uses
- Is Clobazam a controlled substance?Schedule IV
- Generic for SympazanFDA Orange Book
- Benzodiazepines listFDA drug class
- NDC 67386-313Onfi NDC record
- NDC 67386-314Onfi NDC record
- NDC 67386-315Onfi NDC record
- Schedule IV drugs listDEA schedule